Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

Part of paid clinical trials in New York, New York.

Sponsor
Weill Medical College of Cornell University
Study ID
NCT07746427
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
12 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • Digital App Mindfulness Meditation — BEHAVIORAL
    Regular use of a digital mindfulness meditation app 3-4 times per week for 10-15 minutes each session.
  • Mindfulness Meditation Sheet — BEHAVIORAL
    Participants will read an informational handout on mindfulness meditation at the start of the study.

Study Details

Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.

Key Dates

First listed
Aug 5, 2026
Start date
Aug 15, 2026
Status verified
Jul 2026
Primary completion
Jul 31, 2028
Completion
Jul 31, 2028

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Mindfulness Meditation via Digital App
    Participants will use of a mindfulness meditation digital app.
  • Active Comparator: Mindfulness Meditation Sheet
    Participants will read an information sheet on mindfulness meditation.

Primary Outcome Measure

Mean Atopic Dermatitis Control Tool (ADCT) score. [ Time Frame: Pre and post 1 month study observation period. ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Columbia University Irving Medical CenterNew YorkNew York10036
Melissa Stockwell
2123052300
Melissa Stockwell, MD PMH (PRINCIPAL_INVESTIGATOR)
Weill Cornell MedicineNew YorkNew York10021
Dana O'Toole
(646) 962-3410
Dana O'Toole, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

Related Studies